G. Lewis

G. Lewis, D. Archibald, C. Hebert, 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

Rosette formation between murine lymphocytes and erythrocytes. A new locus in the H-2 region

G. Lewis, D. Primi, J. Goodman, 1979, The Journal of experimental medicine.

T-lymphocyte activation by immunogenic determinants.

G. Lewis, S. Fong, D. Nitecki, 1978, Advances in experimental medicine and biology.

Development of Mucosal DNA Vaccines Against HIV-1 Using Live Attenuated Salmonella typhi as a Vaccine-Delivery System

G. Lewis, D. Hone, M. Shata, 2002 .

Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses

G. Cavet, R. Redfield, M. Sajadi, 2018, Cell.

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1

S. Kent, J. Overbaugh, G. Ferrari, 2019, Front. Immunol..

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

M. Pazgier, A. Finzi, G. Lewis, 2015, Viruses.

Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product.

L. Aurelian, G. Lewis, C. Smith, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Molecular immune signatures of HIV‐1 vaccines in human PBMCs

F. Marincola, M. Sabatino, F. Buonaguro, 2009, FEBS letters.

Allosteric induction of the CD4-bound conformation of HIV-1 Gp120

J. Gershoni, Anna Roitburd-Berman, G. Lewis, 2013, Retrovirology.

A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies

F. Kirchhoff, P. Bjorkman, B. Hahn, 2015, Journal of Virology.

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition

M. Sajadi, M. Pazgier, G. Lewis, 2014, Current opinion in HIV and AIDS.

Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178.

Lai-Xi Wang, I. Baskakov, G. Lewis, 2004, Bioorganic & medicinal chemistry.

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

R. Gallo, R. Pal, G. Lewis, 2007, Proceedings of the National Academy of Sciences.

Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.

J. Stephenson, A. Barrett, M. Wills, 1992, Biologicals : journal of the International Association of Biological Standardization.

Survivors Remorse: antibody‐mediated protection against HIV‐1

M. Pazgier, G. Lewis, A. Devico, 2017, Immunological reviews.

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

J. Skurnick, S. Vermund, D. Nixon, 2002, The Journal of infectious diseases.

Immunologic enhancement induced by antibody fragments.

J. Cruse, G. Lewis, G. Gillespie, 1970, Zeitschrift fur Immunitatsforschung, Allergie und klinische Immunologie.

Characterization of the binding of radioiodinated hybrid recombinant IFN-alpha A/D to murine and human lymphoid cell lines.

G. Lewis, C. Faltynek, M. Schwabe, 1990, Journal of interferon research.

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure

M. Pazgier, G. Lewis, K. Ray, 2019, Front. Immunol..

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation

Francesco M. Marincola, Luigi Buonaguro, Ena Wang, 2008, BMC Bioinformatics.

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation

F. Marincola, F. Buonaguro, L. Buonaguro, 2005, Journal of Translational Medicine.

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays

M. Sajadi, A. Harris, G. Lewis, 2020, PloS one.

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays

M. Sajadi, G. Lewis, N. Constantine, 2020, medRxiv.

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

F. Guirakhoo, H. Feldmann, A. Marzi, 2018, Scientific Reports.

Antigen specific T cell hybrids--II. T cell hybrids which bind azobenzenearsonate.

G. Lewis, N. Ruddle, J. Goodman, 1980, Molecular immunology.

Epitope-Binding Molecules From Azobenzenearsonate-Specific Murine T Cells

P. Hornbeck, G. Lewis, D. Primi, 1980 .

Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features

Karen G. Dowell, J. C. Love, C. Bailey-Kellogg, 2021, Retrovirology.

Differential induction of help and suppression in mice by bifunctional antigens administered via different routes.

G. Lewis, D. Nitecki, Z. Kaymakcalan, 1984, Molecular immunology.

ISOLATION AND PRELIMINARY CHARACTERIZATION OF HAPTEN REACTIVE MOLECULES FROM AFFINITY-ENRICHED AZOBENZENEARSONATE-SPECIFIC T CELLS

P. Hornbeck, G. Lewis, J. Goodman, 1979 .

Composite activities on B cells of products released by T cells activated by concanavalin A

G. Lewis, J. Goodman, Daniele Primi, 1979, European journal of immunology.

Idiotype connectance in the immune system. II. A heavy chain variable region idiotope that dominates the antibody response to the p- azobenzenearsonate group is a minor idiotope in the response to trinitrophenyl group

P. Hornbeck, G. Lewis, 1985, The Journal of experimental medicine.

Idiotype profile of an immune response. II. Reversal of the relative dominance of major and minor cross-reactive idiotypes in arsonate- specific T-independent responses

G. Lewis, J. Conger, A. Nisonoff, 1983, The Journal of experimental medicine.

Idiotypic properties of the murine anti-arsonate antibody response: B- and T-cell influences.

G. Lewis, J. Conger, J. Goodman, 1985, Cellular immunology.

Idiotype Connection Between Anti‐Arsonate and Anti‐Dinitrophenyl Responses in BALB/c Mice a

G. Lewis, J. Goodman, John Yao, 1983, Annals of the New York Academy of Sciences.

Role of Fc‐mediated antibody function in protective immunity against HIV‐1

G. Lewis, 2014, Immunology.

Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.

J. Moore, S. Pincus, J. Laman, 1994, AIDS research and human retroviruses.

Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) Transmission

J. Spouge, Mileidy W. Gonzalez, G. Lewis, 2015, Journal of Virology.

Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector.

Shaoguang Wu, G. Lewis, S. Wu, 1997, AIDS research and human retroviruses.

The first 24 h: targeting the window of opportunity for antibody-mediated protection against HIV-1 transmission

G. Lewis, 2016, Current opinion in HIV and AIDS.

Beyond Viral Neutralization.

G. Ferrari, M. Pazgier, A. Finzi, 2017, AIDS research and human retroviruses.

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

W. Blattner, C. Wambebe, R. Gallo, 2002, Journal of human virology.

Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.

R. Tuskan, N. Carbonetti, G. Lewis, 2001, AIDS research and human retroviruses.

Challenges of antibody-mediated protection against HIV-1

G. Lewis, 2010, Expert review of vaccines.

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Jerome H. Kim, X. Chen, H. Liao, 2012, Journal of Virology.

Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells

G. Lewis, K. Ray, A. Devico, 2015, PLoS pathogens.

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.

S. Chada, R. Tuskan, G. Lewis, 1995, Vaccine.

Complement-dependent and -independent pathways of T cell-B cell cooperation.

G. Lewis, R. Ranken, J. Goodman, 1977, Journal of immunology.

Murine B-cell subpopulations responsive to T-dependent and T- independent antigens

G. Lewis, D. Nitecki, R. Ranken, 1976, The Journal of experimental medicine.

A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.

J. Moore, R. Meloen, J. Laman, 1993, AIDS research and human retroviruses.

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain

J. Laman, R. Fouchier, J. Langedijk, 1992, Journal of virology.

Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1

J. Sodroski, J. Moore, J. Robinson, 1994, Journal of virology.

Prolonged survival of murine fibrosarcoma allotransplants by anti-enhancing Fab alloantibody.

J. Cruse, G. Lewis, R. Hester, 1972, Immunological communications.

Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site

M. Pazgier, W. Tolbert, N. Gohain, 2020, BMC Biology.

Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region

M. Pazgier, W. Tolbert, N. Gohain, 2019, Front. Immunol..

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

J. Foulke, M. Sajadi, P. Acharya, 2014, Journal of Virology.

Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.

D. Montefiori, L. Cavacini, G. Lewis, 1998, AIDS research and human retroviruses.

Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Mikulas Popovic, Klara Tenner-Racz, J. van Lunzen, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans

Rachel L. Spreng, Sarah V. Mudrak, G. Ferrari, 2022, npj Vaccines.

Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

P. Wintrode, M. Pazgier, W. Tolbert, 2020, Structure.

Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region.

M. Pazgier, W. Tolbert, N. Gohain, 2017, Structure.

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Karen G. Dowell, J. C. Love, J. Kappes, 2016, The Journal of Immunology.

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

M. Pazgier, W. Tolbert, N. Gohain, 2016, Structure.

Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1

M. Sajadi, P. Acharya, P. Kwong, 2015, Journal of Virology.

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

D. Montefiori, R. Zagursky, C. Labranche, 2015, Proceedings of the National Academy of Sciences.

HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques.

D. Montefiori, D. Venzon, S. Reed, 2014, Virology.

HIV-1 Infection Response Implicated in Reduced Risk for Antibody-Dependent Cellular Cytotoxicity Structural Definition of an

J. Foulke, M. Sajadi, P. Acharya, 2014 .

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

R. Gallo, G. Lewis, A. Devico, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.

W. Blattner, B. Graham, S. Pincus, 1993, The Journal of clinical investigation.

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.

G. Lewis, T. Fouts, D. Hone, 1995, Vaccine.

Intracellular Delivery of a Cytolytic T-Lymphocyte Epitope Peptide by Pertussis Toxin to Major Histocompatibility Complex Class I without Involvement of the Cytosolic Class I Antigen Processing Pathway

R. Tuskan, N. Carbonetti, G. Lewis, 1999, Infection and Immunity.

The anatomy of an antigen molecule: functional subregions of L-tyrosine-p-azobenzenearsonate.

G. Lewis, W. Godfrey, J. Goodman, 1984, Molecular immunology.

In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.

V. Tolstikov, S. Pincus, B. Wahrén, 1996, AIDS research and human retroviruses.

Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization.

A. Garzino-Demo, G. Lewis, Lingling Sun, 2004, International immunology.

Broadly Neutralizing Antibodies against HIV: Back to Blood.

M. Sajadi, G. Lewis, A. Devico, 2019, Trends in molecular medicine.

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques

D. Montefiori, C. Labranche, G. Lewis, 2019, PloS one.

Intrinsic immunogenicity of an internal VP1 T-B epitope pair of type 1 poliovirus.

G. Lewis, C. Feng, 1992, Molecular immunology.

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

M. Reitz, G. Lewis, A. Devico, 2001, Vaccine.

Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response

J. Berzofsky, G. Trinchieri, D. Venzon, 2019, The Journal of clinical investigation.

Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells.

G K Lewis, G. Lewis, M. Parsey, 1993, Journal of immunology.

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

G. Lewis, A. Devico, T. Fouts, 2002, Vaccine.

Cell-targeting antibodies in immunity to Ebola

G. Lewis, A. Schmaljohn, 2016, Pathogens and disease.

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

Sarah V. Mudrak, G. Ferrari, M. A. Moody, 2022, Frontiers in Immunology.

Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.

J. Mcghee, R. Tuskan, G. Lewis, 1996, Journal of biotechnology.

The Role of Immunoglobulin in Receptors and T Cell Mediators in B Lymphocyte Activation

G. Lewis, D. Primi, J. Goodman, 1981 .

The role of immunoglobulin receptors and T cell mediators in B lymphocyte activation. I. B cell activation by anti-immunoglobulin and anti-idiotype reagents.

G. Lewis, D. Primi, J. Goodman, 1980, Journal of immunology.

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay

Y. Hu, R. Koup, G. Ferrari, 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.

G. Lewis, 2013, Current HIV research.

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244

F. H. Damron, M. Barbier, William T. Witt, 2023, Frontiers in Cellular and Infection Microbiology.

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β

R. Gallo, G. Lewis, A. Devico, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

D. Montefiori, R. Gottardo, G. Ferrari, 2021, Vaccine.

An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

R. Gallo, R. Pal, G. Lewis, 2016, Clinical and Vaccine Immunology.

Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy

J. Foulke, M. Pazgier, G. Lewis, 2019, Cell reports.

Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway

George K. Lewis, Sayed F. Abdelwahab, R. Tuskan, 2002, Infection and Immunity.

Replacement of ART with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer.

E. Sausville, A. Heredia, N. Le, 2023, AIDS research and human retroviruses.

Antigenic Properties of the Human Immunodeficiency Virus Envelope during Cell-Cell Fusion

G. Lewis, A. Devico, C. Finnegan, 2001, Journal of Virology.

Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.

M. Pazgier, J. Richard, A. Finzi, 2015, Current HIV research.

HIV-1 transgenic rats develop T cell abnormalities.

M. Reitz, D. Huso, R. Gallo, 2004, Virology.

Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity

R. Redfield, M. Hossain, M. Seaman, 2011, Journal of Acquired Immune Deficiency Syndromes.

Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial

B. Haynes, G. Ferrari, M. A. Moody, 2020, mBio.

Honing a harder-hitting hammerhead improves broadly neutralizing antibody breadth and potency.

G. Lewis, 2015, The Journal of clinical investigation.

Activation of B cell subsets by T-dependent and T-independent antigens.

G. Lewis, R. Ranken, J. Goodman, 1978, Advances in experimental medicine and biology.

Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop

G K Lewis, J. Moore, M. Thali, 1993, Journal of virology.

Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding

D. Chertow, G. Lewis, A. Levine, 2021, medRxiv.

Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015)

R. Gallo, G. Lewis, A. Devico, 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion

G. Lewis, A. Devico, C. Finnegan, 2002, Journal of Virology.

Keeping the barbarian at the gate

G. Lewis, 2006 .

‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands

G. Lewis, A. Devico, Y. Guan, 2008, PloS one.

Synthetic Site-Specific Antibody-Ligand Conjugates Promote Asialoglycoprotein Receptor-Mediated Degradation of Extracellular Human PCSK9.

Qiang Yang, Lai-Xi Wang, Xiao Zhang, 2023, ACS chemical biology.

Arsonate-specific murine T cell clones. II. Delayed-type hypersensitivity induced by P-azobenzenearsonate-L-tyrosine (ABA-Tyr).

G. Lewis, C. Morita, J. Goodman, 1985, Journal of Immunology.

Absence of high-affinity binding sites for interferon alpha/beta in variant murine CD4+ T lymphocytes not expressing the T cell antigen receptor.

G. Lewis, C. Faltynek, R. Kamin-Lewis, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

F. Guirakhoo, H. Feldmann, A. Marzi, 2018, Scientific Reports.

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta.

R. Gallo, G. Lewis, A. Devico, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Arsonate-specific murine T cell clones. III. Correlation between clonotype expression and fine specificity for analogs of L-tyrosine-p-azobenzenearsonate.

G. Lewis, C. Morita, W. Godfrey, 1986, Journal of immunology.

Antigenic Properties of the HIV Envelope on Virions in Solution

J. Lakowicz, G. Lewis, K. Ray, 2013, Journal of Virology.

221 Humoral Immunity against Conserved Epitopes of HIV-1 Envelope Protein Archived in Memory B cells in Natural Viral Suppressors: Discordance with Plasma Antibodies

R. Redfield, R. Gallo, R. Pal, 2009 .

J. Spouge, Mileidy W. Gonzalez, G. Lewis, 2015, Journal of Virology.

Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues

G. Lewis, Krishanu Ray, G. Snyder, 2023, Frontiers in immunology.

P. Hornbeck, G. Lewis, 1985, The Journal of experimental medicine.